AIMS: In patients with coronary artery disease, the 34C > T variant of the adenosine mono-phosphate deaminase gene (AMPD1), encoding a dysfunctional protein, predicts improved survival. We hypothesized that in subjects with this variant allele, ischaemia-induced intracellular adenosine formation is increased, augmenting reactive hyperaemia and ischaemic tolerance. METHODS AND RESULTS: We selected 10 healthy subjects with the CT genotype and 10 CC controls. The forearm vasodilator response to 2 and 5 min of ischaemia (venous occlusion plethysmography, expressed as percentage of maximum blood flow after 13 min of ischaemia) was higher in the CT group 56% (49-74%) and 77% (71-86%) vs. 49% (42-53%) and 60% (55-70%) in the CC group [median (interquartile range), P = 0.01]. Additionally, ischaemia-reperfusion injury was assessed in the thenar muscle using (99m)Tc-annexin A5 scintigraphy after forearm ischaemic exercise to detect externalized membrane phosphatidylserines. At reperfusion, (99m)Tc-annexin was administered intravenously. The change in annexin targeting between 1 and 4 h post-injection was -2.3% (interquartile range -2.4 to -1.6%) in the CT group vs. -0.3% (-0.6 to 1.3%) in controls (n = 7 in both groups, P = 0.03). CONCLUSION: The 34C > T variant of AMPD1 augments vasodilation and reduces tissue injury in response to forearm ischaemia. These mechanisms could contribute to the survival benefit of cardiovascular patients with this variant allele.
AIMS: In patients with coronary artery disease, the 34C > T variant of the adenosine mono-phosphate deaminase gene (AMPD1), encoding a dysfunctional protein, predicts improved survival. We hypothesized that in subjects with this variant allele, ischaemia-induced intracellular adenosine formation is increased, augmenting reactive hyperaemia and ischaemic tolerance. METHODS AND RESULTS: We selected 10 healthy subjects with the CT genotype and 10 CC controls. The forearm vasodilator response to 2 and 5 min of ischaemia (venous occlusion plethysmography, expressed as percentage of maximum blood flow after 13 min of ischaemia) was higher in the CT group 56% (49-74%) and 77% (71-86%) vs. 49% (42-53%) and 60% (55-70%) in the CC group [median (interquartile range), P = 0.01]. Additionally, ischaemia-reperfusion injury was assessed in the thenar muscle using (99m)Tc-annexin A5 scintigraphy after forearm ischaemic exercise to detect externalized membrane phosphatidylserines. At reperfusion, (99m)Tc-annexin was administered intravenously. The change in annexin targeting between 1 and 4 h post-injection was -2.3% (interquartile range -2.4 to -1.6%) in the CT group vs. -0.3% (-0.6 to 1.3%) in controls (n = 7 in both groups, P = 0.03). CONCLUSION: The 34C > T variant of AMPD1 augments vasodilation and reduces tissue injury in response to forearm ischaemia. These mechanisms could contribute to the survival benefit of cardiovascularpatients with this variant allele.
Authors: Castigliano M Bhamidipati; Gaurav S Mehta; Christopher W Moehle; Akshaya K Meher; Gang Su; Navin G Vigneshwar; Carlos Barbery; Ashish K Sharma; Irving L Kron; Victor E Laubach; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi Journal: FASEB J Date: 2013-02-14 Impact factor: 5.191
Authors: P Meijer; C W Wouters; P H H van den Broek; G J Scheffer; N P Riksen; P Smits; G A Rongen Journal: Br J Pharmacol Date: 2008-02-11 Impact factor: 8.739
Authors: Richard Engbersen; Niels P Riksen; Marc J Mol; Bert Bravenboer; Otto C Boerman; Patrick Meijer; Wim J G Oyen; Cees Tack; Gerard A Rongen; Paul Smits Journal: Cardiovasc Diabetol Date: 2012-10-10 Impact factor: 9.951
Authors: Bart P Ramakers; Niels P Riksen; Petra van den Broek; Barbara Franke; Wilbert H M Peters; Johannes G van der Hoeven; Paul Smits; Peter Pickkers Journal: Crit Care Date: 2011-01-06 Impact factor: 9.097
Authors: T N A van den Berg; S El Messaoudi; G A Rongen; P H H van den Broek; A Bilos; A R T Donders; M E Gomes; N P Riksen Journal: PLoS One Date: 2015-10-28 Impact factor: 3.240